Beauty Farm Medical and Health Industry Inc. (stock code: 02373) disclosed a share repurchase executed on 28 November 2025. Prior to the transaction, there were 235,090,068 issued shares (excluding 705,500 treasury shares), and following the repurchase of 80,000 shares, the company noted a closing balance of 235,010,068 issued shares (excluding 785,500 treasury shares). The total number of shares (including treasury shares) remained 235,795,568.
According to the announcement, the 80,000 shares were repurchased on the Hong Kong Stock Exchange at prices ranging between HKD 24.46 and HKD 25.34 per share, resulting in an aggregate consideration of HKD 2,007,420. The repurchased shares are held as treasury shares.
A resolution on 27 June 2025 authorized the repurchase of up to 23,579,556 shares, representing 10% of the then-issued share capital. The company reported that 785,500 shares have been repurchased under the mandate thus far, reflecting approximately 0.3331% of the issued shares at the time the resolution was passed. The announcement also noted a 30-day moratorium period, extending to 27 December 2025, during which time no new shares may be issued or treasury shares sold or transferred without prior approval from the Hong Kong Stock Exchange.
Comments